178 related articles for article (PubMed ID: 22565000)
21. Repurposing to fight cancer: the metformin-prostate cancer connection.
Azvolinsky A
J Natl Cancer Inst; 2014 Feb; 106(2):dju030. PubMed ID: 24511112
[No Abstract] [Full Text] [Related]
22. Efficacious dose of metformin for breast cancer therapy is determined by cation transporter expression in tumours.
Cai H; Everett RS; Thakker DR
Br J Pharmacol; 2019 Aug; 176(15):2724-2735. PubMed ID: 31032880
[TBL] [Abstract][Full Text] [Related]
23. The Effect of Metformin Use during Docetaxel Chemotherapy on Prostate Cancer Specific and Overall Survival of Diabetic Patients with Castration Resistant Prostate Cancer.
Mayer MJ; Klotz LH; Venkateswaran V
J Urol; 2017 Apr; 197(4):1068-1075. PubMed ID: 27984108
[TBL] [Abstract][Full Text] [Related]
24. [What Is the effect of metformin combined to chemotherapy in stage IV colorectal cancer with diabetes?].
Jung JT
Korean J Gastroenterol; 2012 Dec; 60(6):343-4. PubMed ID: 23367542
[No Abstract] [Full Text] [Related]
25. Metformin as an Anticancer Agent.
Vancura A; Bu P; Bhagwat M; Zeng J; Vancurova I
Trends Pharmacol Sci; 2018 Oct; 39(10):867-878. PubMed ID: 30150001
[TBL] [Abstract][Full Text] [Related]
26. Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis.
Vernieri C; Galli F; Ferrari L; Marchetti P; Lonardi S; Maiello E; Iaffaioli RV; Zampino MG; Zaniboni A; De Placido S; Banzi M; Damiani A; Ferrari D; Rosati G; Labianca RF; Bidoli P; Frassineti GL; Nicolini M; Pavesi L; Tronconi MC; Buonadonna A; Ferrario S; Re GL; Adamo V; Tamburini E; Clerico M; Giordani P; Leonardi F; Barni S; Ciarlo A; Cavanna L; Gori S; Cinieri S; Faedi M; Aglietta M; Antista M; Dotti KF; Galli F; Di Bartolomeo M;
Oncologist; 2019 Mar; 24(3):385-393. PubMed ID: 30606884
[TBL] [Abstract][Full Text] [Related]
27. Treatment with metformin is associated with higher remission rate in diabetic patients with thyroid cancer.
Klubo-Gwiezdzinska J; Costello J; Patel A; Bauer A; Jensen K; Mete M; Burman KD; Wartofsky L; Vasko V
J Clin Endocrinol Metab; 2013 Aug; 98(8):3269-79. PubMed ID: 23709654
[TBL] [Abstract][Full Text] [Related]
28. Metformin: an old drug with new potential.
Hajjar J; Habra MA; Naing A
Expert Opin Investig Drugs; 2013 Dec; 22(12):1511-7. PubMed ID: 23978196
[TBL] [Abstract][Full Text] [Related]
29. A pharmacist's perspective on metformin use and cancer outcomes.
Ceacareanu AC
J Pharm Pract; 2015 Feb; 28(1):44-5. PubMed ID: 25715081
[No Abstract] [Full Text] [Related]
30. Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer.
Guppy A; Jamal-Hanjani M; Pickering L
Future Oncol; 2011 Jun; 7(6):727-36. PubMed ID: 21675836
[TBL] [Abstract][Full Text] [Related]
31. Metformin Associated With Improved Outcomes in Diabetic Patients With Laryngeal and Oropharyngeal Carcinoma.
Ogunsakin A; Infield J; Zuber J; Solomon SS
Am J Med Sci; 2018 Dec; 356(6):574-575. PubMed ID: 30342717
[No Abstract] [Full Text] [Related]
32. Repurposing Metformin for Cancer Treatment: A Great Challenge of a Promising Drug.
Saengboonmee C; Sanlung T; Wongkham S
Anticancer Res; 2021 Dec; 41(12):5913-5918. PubMed ID: 34848445
[TBL] [Abstract][Full Text] [Related]
33. Metformin in cancer therapy: a new perspective for an old antidiabetic drug?
Ben Sahra I; Le Marchand-Brustel Y; Tanti JF; Bost F
Mol Cancer Ther; 2010 May; 9(5):1092-9. PubMed ID: 20442309
[TBL] [Abstract][Full Text] [Related]
34. New perspective for an old antidiabetic drug: metformin as anticancer agent.
Leone A; Di Gennaro E; Bruzzese F; Avallone A; Budillon A
Cancer Treat Res; 2014; 159():355-76. PubMed ID: 24114491
[TBL] [Abstract][Full Text] [Related]
35. Metformin and mortality.
Lund SS
Diabetologia; 2013 Apr; 56(4):937-8. PubMed ID: 23377620
[No Abstract] [Full Text] [Related]
36. Antidiabetics, Anthelmintics, Statins, and Beta-Blockers as Co-Adjuvant Drugs in Cancer Therapy.
Gales L; Forsea L; Mitrea D; Stefanica I; Stanculescu I; Mitrica R; Georgescu M; Trifanescu O; Anghel R; Serbanescu L
Medicina (Kaunas); 2022 Sep; 58(9):. PubMed ID: 36143915
[TBL] [Abstract][Full Text] [Related]
37. The effect of metformin on breast cancer outcomes in patients with type 2 diabetes.
Oppong BA; Pharmer LA; Oskar S; Eaton A; Stempel M; Patil S; King TA
Cancer Med; 2014 Aug; 3(4):1025-34. PubMed ID: 24944108
[TBL] [Abstract][Full Text] [Related]
38. Type 2 diabetes and obesity metabolic interactions: common factors for breast cancer risk and novel approaches to prevention and therapy.
Vona-Davis L; Rose DP
Curr Diabetes Rev; 2012 Mar; 8(2):116-30. PubMed ID: 22268396
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model.
Hadad SM; Appleyard V; Thompson AM
Breast Cancer Res Treat; 2009 Mar; 114(2):391. PubMed ID: 18421577
[No Abstract] [Full Text] [Related]
40. Metformin and incident breast cancer among diabetic women: a population-based case-control study in Denmark.
Bosco JL; Antonsen S; Sørensen HT; Pedersen L; Lash TL
Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):101-11. PubMed ID: 21119073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
